About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, May 28th, 2014

The QualityStocks
Daily Stock List


LD Holdings, Inc. (LDHL)

Previously, pressreleasepoint and Stock Guru reported on LD Holdings, Inc. (LDHL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Perrysburg, Ohio-based LD Holdings, Inc. is a Financial and Management Holding Company. The Company’s intention is to attempt to fill a void in the small business world concerning the sale and transfer of businesses from Baby Boomer owners to the next generation. LD Holdings’ focus is on business acquisitions that are successful, with a history of profits and cash flow that may produce Venture Capital returns without Venture Capital start up risks. LD Holdings’ shares trade on the OTC Markets’ OTCQB.

The Company’s particular business model looks to capitalize on this enormous transfer of generational assets, as Baby Boomers transition from ownership of small businesses into retirement having to accept values below their true market value in order to get the business sold. LD Holdings’ focus is on companies of $25 million in revenue or less. The Company will acquire established profitable companies with existing management and personnel, brand equity, customers and cash flow at discounted prices.

LD Holdings’ five year plan is to accumulate a minimum of 45 of these small companies. The Company will work to combine them into cohesive business units whenever possible. In essence, LD Holdings looks to take a seemingly negative funding situation and turn it into a positive one. 

LD Holdings has two operating divisions. One is the Business Services Division, which includes the buyers, managers, as well as investors of the prospective companies. A second division is the Business Operating Division, which will manage the portfolio of companies that LD Holdings will have varying percentages of ownership.

The Company provides marketing, sales, and other business services. These represent target services to position client companies for sales and profit growth in preparation for their eventual sale. In addition, LD Holdings maintains a database of businesses for sale; maintains a database of individuals with specific backgrounds and expertise for acquisition, evaluation, and strategizing the post-acquisition business model, and maintains a database of investors.

LD Holdings’ intention is to concentrate its efforts on becoming a "known buyer" of small companies that meet its acquisition criteria, which it intends to extensively distribute to business sellers directly and to others on its websites. Its goal, by way of aggressive use of the Internet, is to put an outside investor base in place that shares its vision and objectives while the search for acquisitions is taking place.

LD Holdings’ plan is to acquire a minimum of three companies with $25 million sales and EBIT of $2.5 million. It is establishing an Area Sales Director Business Model in a three state area (Ohio, Michigan and Indiana) at first. If this three state model proves successful, it would proceed with a national rollout.

LD Holdings, Inc. (LDHL), closed Wednesday's trading session at $0.56, up 3.68%, on 2,020 volume with 2 trades. The average volume for the last 60 days is 7,583 and the stock's 52-week low/high is $0.30/$0.8999.

StrikeForce Technologies, Inc. (SFOR)

Real Pennies reported recently on StrikeForce Technologies, Inc. (SFOR), PennyStocks24, SmallCapFinancialWire, Top Stock Picks did earlier, and today we report on the Company, here at the QualityStocks Daily Newsletter.

StrikeForce Technologies, Inc. specializes in Cyber Security solutions for the prevention of Data Breaches and Identity Theft. Its products help protect consumers and their families while banking and shopping online, and businesses in "real time" against data loss and breaches. The Company is the leading provider of Out-of-Band Authentication, Keystroke Encryption, and Mobile Security. StrikeForce Technologies has its corporate headquarters in Edison, New Jersey. The Company’s shares trade on the OTC Markets’ OTCQB.

StrikeForce offers ProtectID (Out-of-Band Authentication). ProtectID can be managed on premise or through the Company’s hosted cloud service. The design of ProtectID is to deliver affordable, flexible, and redundant authentication for banks, corporations, universities, government agencies, and social networking websites.

Furthermore, the Company offers GuardedID. It protects an individual by encrypting their keystrokes when they bank, shop, and email online. In addition, StrikeForce Technologies offers MobileTrust Mobile Security. This is the most advanced security suite for Apple and Android mobile devices. It protects user credentials, passwords, online transactions, and access to corporate networks.

This past November, StrikeForce Technologies announced a strategic partnership with VigiTrust, the industry's leading Security Awareness and PCI Compliance Specialist. The new PCI-DSS 3.0 standard became effective January 1, 2014. It was developed to encourage and enhance cardholder data security and facilitate the wide-ranging adoption of consistent data security measures worldwide.

For organizations to meet these new PCI security requirements, they must implement security solutions allowing entities to assign a unique ID to each user, track system component usage, and encrypt data in transit and at rest. StrikeForce Technologies’ patented ProtectID® Multi-Factor Authentication technology and GuardedID® Keystroke Encryption technologies enable this and help decrease PCI-DSS scope for merchants and PSPs.

StrikeForce Technologies this year launched two mobile products. GuardedID Mobile™ is a Software Developers Kit (SDK). It is the industry's "only" patented (#8,566,608) Keystroke Encryption Technology available for Apple and Android mobile applications. MobileTrust® is the industry's most advanced security suite for Apple & Android mobile devices. It protects user credentials, passwords, online transactions, and access to corporate networks.

This month, StrikeForce Technologies announced that it was granted its third patent for "Multi-Channel Device Utilizing A Centralized Out-of-Band Authentication System" from the United States Patent Office (Patent No. 8,713,701).

StrikeForce Technologies, Inc. (SFOR), closed Wednesday's trading session at $0.07, even for the day, on 38,510 volume with 9 trades. The average volume for the last 60 days is 132,673 and the stock's 52-week low/high is $0.02/$7.8571.

Enertopia Corp. (ENRT)

Flagler Financial Group, Wallstreetbuzz, Shiznit Stocks, PennyStocks24, MassiveStockProfits, Vantage Wire, Wallstreetlivechat, Stocks To Watch, Pennybuster, Stock Twiter, Penny Champions, Penny Dreamers, Jet-Life Penny Stocks, and Pennystocktweeters.com reported on Enertopia Corp. (ENRT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed Enertopia Corp. centers on low risk, high reward projects that it believes will generate shareholder value by way of timely acquisition and full development across varied industries. The Company is focusing on the growing Canadian Medical Marijuana business opportunity. Enertopia also intends to acquire and develop low risk oil & gas projects in onshore locations in North America. Founded in 2004, the Company formerly went by the name Golden Aria Corp. It changed its name to Enertopia Corp. in February of 2010.

Pertaining to oil & gas, Enertopia is currently focusing on the development of the 100 well Pennsylvania light oil opportunity. To date, the vendor has drilled 41 oil wells with a 100 percent success rate. The Pennsylvania light oil opportunity has four productive sands. Each well has the potential for up to four zones to produce from. In addition, Enertopia provides wide-ranging services in the clean energy and clean water sectors. The Company provides clean energy audits, solar PV, solar thermal, waste heat and energy recovery and efficiency, solar or wind-powered water filtration, and system design and installation.

Enertopia signed a Joint Venture (JV) Agreement with the World of Marihuana Productions Ltd. formally known as 0984321 B.C. Ltd. under the Letter of Intent (LOI) dated November 4, 2013. The Company paid $100,000 USD and issued 5,000,000 shares of common stock on signing the (JV) Agreement. It can earn up to a 51 percent net revenue interest (NRI) in the JV. 

This past March, Lexaria Corp. reported that its Board decided to make a strategic entry into the medical marihuana business through an important Joint Venture with Enertopia. Mr. Robert McAllister, Chief Executive Officer and Chair of Enertopia, agreed to join the Advisory Board of Lexaria to evaluate and negotiate marihuana acquisitions and joint ventures. Lexaria agreed to pay Enertopia 1 million restricted common shares in return for Enertopia's participation. Lexaria also agreed to pay 500,000 restricted common shares to Mr. McAllister in return for his participation on the Lexaria Advisory Board. 

Enertopia Corp. (ENRT), closed Wednesday's trading session at $0.164, down 4.87%, on 269,005 volume with 52 trades. The average volume for the last 60 days is 962,124 and the stock's 52-week low/high is $0.012/$1.08.

Patriot Scientific Corp. (PTSC)

Greenbackers reported earlier on Patriot Scientific Corp. (PTSC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Patriot Scientific Corp. is an intellectual-property (IP) licensing company with a number of patents, which are fundamental to modern microprocessor design. It is the co-owner of the Moore Microprocessor Patent Portfolio™ (MMP Portfolio™). The Company’s patents, collectively known as the MMP Portfolio™, are licensed via its joint-venture, Phoenix Digital Solutions (PDS). Patriot Scientific has its corporate headquarters in Carlsbad, California. The Company’s shares trade on the OTC Markets’ OTCQB.

Patriot Scientific had previous experience developing unique microprocessor architectured chips. Consequently, the Company started offering the core of its chip technology in the form of licensable intellectual property (IP). 

The MMP Portfolio™ includes United States patents and their European and Japanese counterparts. These cover techniques that enable higher performance and lower cost designs vital to consumer and commercial digital systems. These range from personal computers (PCs), cell phones and portable music players, to communications infrastructure, medical equipment, as well as automobiles.

PDS is the joint venture that aggregates the ownership interests in the Moore Microprocessor Patent™ (MMP) Portfolio, facilitating the unified marketing and licensing of the patents. Patriot Scientific is a 50 percent owner in PDS. Currently, the Company’s focus is the licensing of the MMP Portfolio™. To date, more than 100 companies have licensed the MMP Portfolio.

The MMP Portfolio has been tested by way of challenges at the U.S. Patent and Trademark Office. The MMP Portfolio has survived 17 re-examination challenges.

This past March, Patriot Scientific announced that it has been seeking the appointment of a new and independent third member to the management committee of Phoenix Digital Solutions (PDS). The Company has started an arbitration process for the selection of this third member. Patriot Scientific believes the appointment of an independent member to the PDS Management Committee will facilitate decision-making in the best interests of the joint venture.

Patriot Scientific Corp. (PTSC), closed Wednesday's trading session at $0.05, up 5.93%, on 77,000 volume with 7 trades. The average volume for the last 60 days is 422,058 and the stock's 52-week low/high is $0.038/$0.248.

Skinvisible, Inc. (SKVI)

PennyStocks24, Xtremepicks, OurHotStockPicks, and Penny Stock Whispers reported recently on Skinvisible, Inc. (SKVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Skinvisible, Inc., via its wholly owned subsidiary, Skinvisible Pharmaceuticals, Inc. is a research & development (R&D) company that lists on the OTC Markets’ OTCQB. The Company licenses its proprietary formulations made with Invisicare, its patented polymer delivery system, which provides life-cycle management and unique enhancements for topically delivered products. Skinvisible continually generates new IP on topical products formulated with Invisicare. Skinvisible is based in Las Vegas, Nevada.

The Company’s Invisicare holds active ingredients on the skin for extended periods of time resisting wash off and perspiration along with controlling the release of actives and reducing irritation. Skinvisible receives a combination of R&D fees, upfront license fees, as well as ongoing royalties for the life of the Invisicare patent.

Skinvisible has developed a portfolio of more than 40 topical products using Invisicare (prescription, Over-The-Counter (OTC) and cosmeceutical). In addition, it works directly with companies to enhance their products, particularly ones coming off patent. Invisicare can be tailored to almost any kind of molecule and the requirements of the Company’s customers.

Earlier this month, the Company announced that Skinvisible Pharmaceuticals received notification from the Federal Public Service (FPS) Health, Food Chain Safety and Environment in Belgium that it has extended the registration of DermSafe for an additional ten years - until December 31, 2024. DermSafe is its unique antimicrobial hand sanitizer. DermSafe's approval in Belgium will act as the "Reference Member State" which will be leveraged for more authorization throughout Europe. DermSafe is a non-alcohol hand sanitizer made with 4% chlorhexidine gluconate. This has demonstrated persistent protection of both gram-negative and gram-positive bacteria and viruses through independent laboratory studies.

Today, Skinvisible Pharmaceuticals announced that it was granted a new patent by the United States Patent and Trademark Office (USPTO) entitled, "Cationic Pharmaceutically Active Ingredient Containing Composition, and Methods for Manufacturing and Using" (Patent #8,735,422). The patent provides formulation protection until April 2030. It covers the composition of formulations developed with cationic actives in combination with Skinvisible Pharmaceutical’s proprietary polymer delivery system, Invisicare. Furthermore, the Company has filed a divisional patent application seeking additional claims.

Skinvisible, Inc. (SKVI), closed Wednesday's trading session at $0.0338, up 12.67%, on 357,426 volume with 9 trades. The average volume for the last 60 days is 147,011 and the stock's 52-week low/high is $0.01/$0.049.


The QualityStocks
Company Corner


WordLogic Corp. (WLGC)

The QualityStocks Daily Newsletter would like to spotlight WordLogic Corp. (WLGC). Today, WordLogic Corp. closed trading at $0.14, up 3.70%, on 368,063 volume with 65 trades. The stock’s average daily volume over the past 60 days is 368,063, and its 52-week low/high is $0.065/$0.28.

WordLogic Corp. reported today that they are currently in discussions with a mobile app provider that has millions of users, to substantially increase their revenue by integrating Reach™ Advertising Search into their mobile platform. Reach™ is groundbreaking intelligent messaging technology that allows users to add context-aware information into messages, emails and forms without needing to switch through other apps or search their devices, technology which dovetails exceptionally well with the company's own predictive intelligence technology.

WordLogic Corp. (WLGC) leverages more than 10 years of advanced R&D to assume its position as a global leader in predictive text input technology. Backed by multiple patents and its predictive engine, WordLogic’s interface is revolutionizing the way individuals and businesses search and communicate on touch screen devices. Furthermore, WordLogic offers a range of licensing options of its technology and patent portfolio.

The company’s technology incorporates proprietary Gesturing™ and WordChunking™ features that accelerate typing speeds while reducing the effort needed for accuracy. This interface increased text input on mobile devices by five times, rapidly speeding communication via instant messaging, text messaging, captioning, email and information searching. The iKnowU® keyboard uses state-of-the-art patented technology that becomes more accurate with each use, constantly learning about the user’s style and preferences. Utilizing the WordChunking and Gesturing, iKnowU enables the user to chain together phrases and create whole sentences in a matter of seconds.

For the business realm, WordLogic has developed a unique cloud solution to fit the specific needs of multiple industry sectors, enabling enterprises to create a single cloud-based dictionary specific to the company’s realm of expertise or multiple dictionaries specific for individual specialties or departments. This cloud solution creates continuity for users across multiple devices, boosting accuracy and productivity. WordLogic Reach™ enables users to select and insert meeting plans, contact information, and calendar entries from other apps in the mobile device.

Frost & Sullivan recently recognized WordLogic as the recipient of the 2014 North American Enabling Technology Leadership Award for Predictive Keyboard Applications, saying, “WordLogic’s technically impressive product - WordLogic Predictive Engine and its associated products iKnowU® and Reach™ - offers key competitive advantages, such as market-leading word and phrase prediction capabilities, a context-aware advertising model; simpler integration, increased speed and accuracy; and reduced costs. Add to that the significant number of pending and issued patents and you can see how value a package of technology WordLogic has developed truly is.” Disclaimer

WordLogic Corp. Company Blog

WordLogic Corp. News:

WordLogic Engages in Venture Discussions With Prominent Mobile App Provider

WordLogic Pre-Releases Award-Winning iKnowU Keyboard With REACH™ to Interested Developers and Partners

WordLogic Corp. Announces Engagement of QualityStocks Investor Relations Services

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.64, up 59.60%, on 2,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 4,995, and its 52-week low/high is $0.25/$0.89.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Joins HESI's Cardiac Safety Committee and Working Groups

VistaGen Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine

VistaGen Joins the Cardiac Safety Research Consortium

Raptor Resources Holdings Inc. (RRHI)

The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, Raptor Resources Holdings Inc. closed trading at $0.0125, up 2.46%, on 21,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 47,500, and its 52-week low/high is $0.0051/$0.039.

Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.

Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.

TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.

RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer

Raptor Resources Holdings Inc. Company Blog

Raptor Resources Holdings Inc. News:

Raptor Resources Holdings Issues Update on the Derbyshire Stone Quarry

Raptor Resources Holdings Acquires the Derbyshire Stone Quarry

Raptor Resources Holdings Completes Expansion of the Dodge Mine Mountain Range

Armco Metals Holdings, Inc. (AMCO)

The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.22, up 1.34%, on 299,187 volume with 314 trades. The stock’s average daily volume over the past 60 days is 537,867, and its 52-week low/high is $0.20/$0.58.

Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has worked tirelessly to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.

Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.

Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.

Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer

Armco Metals Holdings, Inc. Company Blog

Armco Metals Holdings, Inc. News:

Armco Metals Holdings, Inc. Receives $15 Million Credit Approval From a Chinese Commercial Bank

Armco Metals Holdings Announces Financial Results for the First Quarter of 2014

Armco Metals Holdings Enters Into Scrap Steel Distribution Agreement With TEWOO Metals International Trade Co., Ltd.

NutraNomics, Inc. (NNRX)

The QualityStocks Daily Newsletter would like to spotlight NutraNomics, Inc. (NNRX). Today, NutraNomics, Inc. closed trading at $0.0821, even for the day, on 250 volume with 1 trade. The stock’s average daily volume over the past 60 days is 200,099, and its 52-week low/high is $0.0605/$1.48.

NutraNomics, Inc. (NNRX) is focused on the research and development of nutritional dietary supplements, skin and body care products and transdermal patches. In addition to creating formulas for hundreds of companies, the company has produced and branded its own product lines which are sold through retail and wholesale channels. Additionally the company private labels and does custom manufacturing for several supplement companies in national and international markets.

Nearly all vitamins currently on the market are isolated and/or synthetic. The human body doesn’t recognize these types of vitamins and as a result cannot absorb them because they are either missing critical nutritional components or are not food based. NutraNomics has rapidly grown its business over the past 18 years by offering superior food and plant-based products blended from the highest quality sources available for maximum bioavailability.

Today NutraNomics has sales teams in seven different countries promoting its diversified line of wholefood-based supplements, specialty formulas, and remedies. All facilities used to produce the gluten-free, non-GMO nutritional products are cGMP Compliant and FDA approved. To ensure the highest purity potency and quality, the company takes it another step forward by performing additional content testing on all raw materials used to manufacture its products.

NutraNomics is more than just a health supplement provider. As a company dedicated to supporting the worldwide community of people who want to live healthy, NutraNomics is making an impact on those who are suffering from various types of diseases that need specialized diet to enhance their lifestyle. To fulfill this mission NutraNomics has invested in clinical studies for controlling diabetes, heart disease and cancer with dietary supplements. Strong growth is anticipated to continue as the company continues to introduce cutting-edge products and taps into new markets. Disclaimer

NutraNomics, Inc. Company Blog

NutraNomics, Inc. News:

Nutranomics Discusses Long-Term Global Expansion Strategy with UNO International Corp.

Nutranomics Receives Initial Purchase Order from Leading Health Products Distributor in the Philippines

Nutranomics Announces Exclusive Shareholder Product Promotion


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251